Scientific SponsorMarket Research Reports |
Antibody Engineering:
|
|||||
![]() |
Evolving Technologies of Antibody Engineering Michael L. Neuberger, Ph.D., Head, Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, United Kingdom |
![]() |
Antibodies: Versatile Proteins for Multiple Applications Sherie Morrison, Ph.D., Chair, Department of Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles |
Cutting-Edge Presentations from a Preeminent Internationally Recognized Faculty
As an attendee for the Antibody Engineering meeting, you may also attend the sessions of the 6th Annual Antibody Therapeutics conference at no additional charge. This three-day program runs concurrent with Antibody Engineering from Tuesday-Thursday (December 9-11), and presentations feature over twenty updates on clinical and preclinical stage industry antibody programs, business and legal updates and much more!
Holding these two events together allows you to move freely among the sessions of both events and customize your conference experience to meet the needs of you and your organization. This unique meeting provides you with networking opportunities not available at any other antibody conference. Participants may network with more than 700 colleagues, explore exhibits showcasing new research technologies, and interact with speakers as well as poster authors.